TODD STRATEGY GROUP for EXACT SCIENCES CORPORATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and/or FDA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M TODD New | Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid |
Medical/Disease Research/Clinical Labs MED
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act. Implementation of changes to Medicare payment for clinical laboratory tests. FDA regulation of laboratory tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and/or FDA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M TODD New | Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.